The FDA is supposed to monitor adverse drug reactions after drugs are approved and put on the market. It collects information in a huge database to try to spot problems. But a handful of researchers tucked away in a university are using a completely different approach--and spotting problems years before the FDA could. Find out how these medical detectives do it.
Outpacing the FDA: Finding Adverse Drug Reactions
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The FDA is supposed to monitor adverse drug reactions after drugs are approved and put on the market. It collects information in a huge database to try to spot problems. But a handful of researchers tucked away in a university are using a completely different approach--and spotting problems years before the FDA could. Find out how these medical detectives do it.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
HF Management for Patients with Comorbid Conditions
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
FINE-HEART Pooled Analysis
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?